Editorial (Thematic Issue: The Biological Approach to Advanced Cancer: Are We in the Middle of the Road?)

Curr Drug Targets. 2016;17(10):1102. doi: 10.2174/138945011710160624160945.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antineoplastic Agents / therapeutic use*
  • Drug Therapy, Combination
  • Humans
  • Neoplasms / drug therapy*

Substances

  • Antibodies, Monoclonal
  • Antineoplastic Agents